About: Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.99 (-1.24%)
QNRX NASDAQ Quoin Pharmaceuticals Ltd DRC
Quoin Pharmaceuticals Ltd DRC share price
Atividade de preço de QNRX
Último preço
$ 3,990
Variação (24h)
-0,05 USD (1,24%)
Volume
7.75K
Volume (média 4 sem.)
-
Abertura
$ 4,01
Variação do dia
$ 3,99 - $ 4,19
Fechamento anterior
$ 4,04
Último negócio
21 Oct, 8:00 pm GMT+0
Atrasado
21 Oct, 8:00 pm GMT+0
QNRX price performance
Atrasado
21 Oct, 8:00 pm GMT+0
quote.marketSignals